Calavo Growers experienced a mixed third quarter in 2025. While total net sales remained relatively flat, the Fresh segment saw a decline in sales and gross profit due to lower avocado and tomato volumes and significant costs from an FDA detention hold. In contrast, the Prepared segment delivered strong growth in both sales and gross profit, driven by increased volumes and improved operational efficiency. The company's net income and EPS decreased, but adjusted net income and adjusted EBITDA increased year-over-year.
Total net sales for Q3 2025 were $178.8 million, a decrease of less than one percent from the prior year.
The Fresh segment's sales decreased by 5% to $155.9 million, primarily due to an 8% decrease in cartons sold and a $4.2 million impact from an FDA detention hold.
The Prepared segment's sales increased by 40% to $22.9 million, driven by a 35% increase in sales volume.
Net income from continuing operations attributable to Calavo Growers, Inc. was $4.7 million, or $0.26 per diluted share, down from $5.4 million, or $0.30 per diluted share, in the prior year.
Calavo Growers anticipates continued growth, particularly in its Prepared segment, with the resolution of the FDA matter and a favorable legal development in Mexico expected to positively impact future performance.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance